Joel Greenblatt Neurocrine Biosciences Inc Transaction History
Gotham Asset Management, LLC
- $11.5 Billion
- Q1 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 31,023 shares of NBIX stock, worth $3.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
31,023
Previous 5,714
442.93%
Holding current value
$3.9 Million
Previous $779,000
340.44%
% of portfolio
0.03%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.25 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$696 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$611 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$336 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...